Thermo Fisher Scientific Analyst Ratings
Thermo Fisher Scientific Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/26/2023 | 20.18% | Citigroup | $625 → $530 | Maintains | Buy |
10/26/2023 | 16.78% | Raymond James | $580 → $515 | Maintains | Outperform |
10/26/2023 | 23.58% | Morgan Stanley | $600 → $545 | Maintains | Overweight |
10/26/2023 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
10/24/2023 | 36.05% | Morgan Stanley | $640 → $600 | Maintains | Overweight |
10/18/2023 | 31.52% | Raymond James | $630 → $580 | Maintains | Outperform |
10/17/2023 | 42.86% | JP Morgan | $670 → $630 | Maintains | Overweight |
10/02/2023 | 41.72% | Citigroup | $625 → $625 | Reiterates | Buy → Buy |
09/28/2023 | 36.73% | Bernstein | → $603 | Initiates Coverage On | → Outperform |
09/06/2023 | 41.72% | Citigroup | → $625 | Reinstates | Buy → Buy |
07/28/2023 | 17.91% | Wells Fargo | $505 → $520 | Maintains | Underweight |
07/28/2023 | 42.86% | Raymond James | $595 → $630 | Maintains | Outperform |
07/27/2023 | 45.12% | Morgan Stanley | $620 → $640 | Maintains | Overweight |
07/27/2023 | 58.28% | RBC Capital | $662 → $698 | Maintains | Outperform |
07/27/2023 | 51.93% | JP Morgan | $660 → $670 | Maintains | Overweight |
07/27/2023 | 41.72% | Baird | $664 → $625 | Maintains | Outperform |
07/27/2023 | 41.72% | Barclays | $590 → $625 | Maintains | Overweight |
07/13/2023 | 40.59% | Credit Suisse | → $620 | Upgrades | Neutral → Outperform |
05/25/2023 | 49.66% | JP Morgan | $675 → $660 | Maintains | Overweight |
05/25/2023 | 45.12% | Keybanc | $710 → $640 | Maintains | Overweight |
04/27/2023 | 47.39% | Citigroup | $700 → $650 | Maintains | Buy |
04/27/2023 | 50.11% | RBC Capital | $664 → $662 | Maintains | Outperform |
04/27/2023 | 40.59% | Morgan Stanley | $670 → $620 | Maintains | Overweight |
04/27/2023 | 57.14% | TD Cowen | $711 → $693 | Maintains | Outperform |
04/27/2023 | 51.93% | Baird | $693 → $670 | Maintains | Outperform |
04/27/2023 | 38.32% | Barclays | $625 → $610 | Maintains | Overweight |
04/04/2023 | 38.32% | Evercore ISI Group | $615 → $610 | Maintains | Outperform |
04/04/2023 | 41.72% | Barclays | $660 → $625 | Maintains | Overweight |
02/02/2023 | 53.06% | JP Morgan | $650 → $675 | Maintains | Overweight |
02/02/2023 | 61.22% | Cowen & Co. | $690 → $711 | Maintains | Outperform |
02/02/2023 | 58.73% | Citigroup | $650 → $700 | Maintains | Buy |
02/02/2023 | 51.93% | Morgan Stanley | $613 → $670 | Maintains | Overweight |
02/02/2023 | 49.66% | Barclays | $630 → $660 | Maintains | Overweight |
02/02/2023 | 42.86% | SVB Leerink | $620 → $630 | Maintains | Outperform |
01/24/2023 | 42.86% | Barclays | $570 → $630 | Maintains | Overweight |
01/06/2023 | 40.59% | SVB Leerink | $555 → $620 | Maintains | Outperform |
01/03/2023 | 14.51% | Wells Fargo | $525 → $505 | Maintains | Underweight |
12/14/2022 | 40.59% | Deutsche Bank | → $620 | Initiates Coverage On | → Buy |
12/07/2022 | 49.89% | RBC Capital | → $661 | Initiates Coverage On | → Outperform |
11/29/2022 | 29.25% | Barclays | $575 → $570 | Maintains | Overweight |
11/01/2022 | 50.79% | Baird | $695 → $665 | Maintains | Outperform |
10/27/2022 | 47.39% | JP Morgan | $715 → $650 | Maintains | Overweight |
10/27/2022 | 47.39% | Citigroup | $715 → $650 | Maintains | Buy |
10/27/2022 | 30.39% | Barclays | $595 → $575 | Maintains | Overweight |
10/27/2022 | 39% | Morgan Stanley | $678 → $613 | Maintains | Overweight |
10/27/2022 | 25.85% | SVB Leerink | $590 → $555 | Maintains | Outperform |
09/12/2022 | 34.92% | Barclays | $685 → $595 | Maintains | Overweight |
08/25/2022 | 53.06% | Credit Suisse | → $675 | Initiates Coverage On | → Neutral |
08/01/2022 | 55.33% | Barclays | $630 → $685 | Maintains | Overweight |
07/29/2022 | 62.13% | JP Morgan | $700 → $715 | Maintains | Overweight |
07/29/2022 | 53.74% | Morgan Stanley | $670 → $678 | Maintains | Overweight |
07/29/2022 | 47.39% | SVB Leerink | $630 → $650 | Maintains | Outperform |
07/13/2022 | 42.86% | Barclays | $675 → $630 | Maintains | Overweight |
04/29/2022 | 51.93% | Morgan Stanley | $700 → $670 | Maintains | Overweight |
04/25/2022 | 19.05% | Wells Fargo | $605 → $525 | Downgrades | Equal-Weight → Underweight |
02/03/2022 | 37.19% | Wells Fargo | $700 → $605 | Maintains | Equal-Weight |
12/14/2021 | 58.73% | Wells Fargo | $625 → $700 | Maintains | Equal-Weight |
10/28/2021 | 62.13% | Citigroup | $700 → $715 | Maintains | Buy |
10/28/2021 | 55.33% | SVB Leerink | $675 → $685 | Maintains | Outperform |
10/20/2021 | 58.73% | Citigroup | $620 → $700 | Upgrades | Neutral → Buy |
09/23/2021 | 48.53% | Cowen & Co. | $560 → $655 | Maintains | Outperform |
09/22/2021 | 58.73% | BTIG | $610 → $700 | Maintains | Buy |
09/20/2021 | 58.73% | JP Morgan | $600 → $700 | Maintains | Overweight |
09/20/2021 | 61% | Keybanc | $555 → $710 | Maintains | Overweight |
08/04/2021 | 36.05% | Argus Research | $530 → $600 | Maintains | Buy |
07/29/2021 | 36.05% | JP Morgan | $560 → $600 | Maintains | Overweight |
07/16/2021 | 31.52% | Benchmark | → $580 | Initiates Coverage On | → Buy |
07/12/2021 | 25.85% | Keybanc | $520 → $555 | Maintains | Overweight |
06/23/2021 | 24.72% | Baird | $545 → $550 | Maintains | Outperform |
06/15/2021 | 20.18% | Goldman Sachs | $590 → $530 | Maintains | Buy |
04/16/2021 | 22.45% | Evercore ISI Group | $525 → $540 | Maintains | Outperform |
03/29/2021 | 26.98% | UBS | $588 → $560 | Maintains | Buy |
03/18/2021 | 17.91% | Keybanc | → $520 | Upgrades | Sector Weight → Overweight |
03/03/2021 | 19.05% | Barclays | → $525 | Initiates Coverage On | → Overweight |
02/03/2021 | 33.79% | BTIG | $540 → $590 | Maintains | Buy |
02/02/2021 | 20.18% | Citigroup | $500 → $530 | Maintains | Buy |
02/02/2021 | 33.33% | UBS | $566 → $588 | Maintains | Buy |
02/02/2021 | 32.65% | Cowen & Co. | $525 → $585 | Maintains | Outperform |
02/02/2021 | 36.05% | Stifel | $530 → $600 | Maintains | Buy |
02/02/2021 | 30.39% | Morgan Stanley | $535 → $575 | Maintains | Overweight |
02/02/2021 | 26.98% | SVB Leerink | $525 → $560 | Maintains | Outperform |
01/12/2021 | 31.52% | Credit Suisse | $556 → $580 | Maintains | Outperform |
01/08/2021 | 26.08% | Credit Suisse | $490 → $556 | Upgrades | Neutral → Outperform |
12/16/2020 | — | Citigroup | Downgrades | Buy → Neutral | |
12/02/2020 | 11.11% | Credit Suisse | $488 → $490 | Maintains | Neutral |
11/10/2020 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
10/22/2020 | 10.66% | Credit Suisse | $432 → $488 | Maintains | Neutral |
10/22/2020 | 21.32% | Morgan Stanley | $485 → $535 | Maintains | Overweight |
10/22/2020 | 19.05% | SVB Leerink | $470 → $525 | Maintains | Outperform |
09/30/2020 | — | Atlantic Equities | Initiates Coverage On | → Overweight | |
09/17/2020 | 8.16% | Needham | $468 → $477 | Maintains | Buy |
09/14/2020 | 9.98% | Morgan Stanley | → $485 | Initiates Coverage On | → Overweight |
09/11/2020 | 8.84% | B of A Securities | $460 → $480 | Maintains | Buy |
09/11/2020 | -2.04% | Credit Suisse | $425 → $432 | Maintains | Neutral |
09/11/2020 | 6.58% | SVB Leerink | $455 → $470 | Maintains | Outperform |
08/21/2020 | -3.63% | Credit Suisse | $405 → $425 | Maintains | Neutral |
08/20/2020 | 4.31% | JP Morgan | → $460 | Reinstates | → Overweight |
07/23/2020 | 6.12% | Needham | $415 → $468 | Maintains | Buy |
07/23/2020 | 3.17% | SVB Leerink | $365 → $455 | Maintains | Outperform |
07/15/2020 | — | Cleveland Research | Upgrades | Neutral → Buy | |
07/07/2020 | -5.9% | Needham | $383 → $415 | Maintains | Buy |
04/23/2020 | -11.56% | Citigroup | $365 → $390 | Maintains | Buy |
04/23/2020 | -13.15% | Needham | $341 → $383 | Maintains | Buy |
04/21/2020 | -22.9% | Wells Fargo | $300 → $340 | Maintains | Equal-Weight |
04/02/2020 | -28.57% | Stifel | $345 → $315 | Maintains | Buy |
03/30/2020 | -31.97% | Wells Fargo | $345 → $300 | Maintains | Equal-Weight |
03/20/2020 | -17.23% | Citigroup | $390 → $365 | Maintains | Buy |
03/04/2020 | -22.68% | Baird | $340 → $341 | Maintains | Outperform |
01/31/2020 | -15.65% | BTIG | $342 → $372 | Maintains | Buy |
01/31/2020 | -22.9% | Baird | $319 → $340 | Maintains | Outperform |
01/31/2020 | -21.77% | Wells Fargo | $350 → $345 | Maintains | Equal-Weight |
01/31/2020 | -11.56% | Citigroup | $380 → $390 | Maintains | Buy |
01/22/2020 | -22.68% | Credit Suisse | → $341 | Initiates Coverage On | → Neutral |
01/08/2020 | -20.63% | Wells Fargo | → $350 | Initiates Coverage On | → Equal-Weight |
01/07/2020 | -13.83% | Citigroup | → $380 | Initiates Coverage On | → Buy |
11/15/2019 | -21.77% | Stifel | → $345 | Initiates Coverage On | → Buy |
10/24/2019 | -27.66% | Baird | $305 → $319 | Maintains | Outperform |
07/25/2019 | -27.21% | Needham | $315 → $321 | Maintains | Buy |
07/16/2019 | -28.57% | Needham | → $315 | Downgrades | Strong Buy → Buy |
05/23/2019 | -27.44% | UBS | $305 → $320 | Maintains | Buy |
05/01/2019 | -29.71% | Argus Research | $285 → $310 | Maintains | Buy |
03/26/2019 | -34.69% | Baird | $270 → $288 | Maintains | Outperform |
03/22/2019 | -31.97% | Deutsche Bank | $275 → $300 | Maintains | Buy |
03/18/2019 | -31.97% | Barclays | $295 → $300 | Maintains | Overweight |
01/03/2019 | -36.51% | Barclays | $275 → $280 | Maintains | Overweight |
01/03/2019 | -38.55% | Needham | → $271 | Initiates Coverage On | → Strong Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
2023年10月26日 | 20.18% | 花旗集團 | $625→$530 | 維護 | 買 |
2023年10月26日 | 16.78% | 雷蒙德·詹姆斯 | $580→$515 | 維護 | 跑贏大盤 |
2023年10月26日 | 23.58% | 摩根士丹利 | $600→$545 | 維護 | 超重 |
2023年10月26日 | - | KeyBanc | 評級下調 | 增持→板塊權重 | |
2023年10月24日 | 36.05% | 摩根士丹利 | $640→$600 | 維護 | 超重 |
10/18/2023 | 31.52% | 雷蒙德·詹姆斯 | $630→$580 | 維護 | 跑贏大盤 |
10/17/2023 | 42.86% | 摩根大通 | $670→$630 | 維護 | 超重 |
10/02/2023 | 41.72% | 花旗集團 | $625→$625 | 重申 | 購買→購買 |
09/28/2023 | 36.73% | 伯恩斯坦 | →$603 | 開始承保 | →跑贏大盤 |
09/06/2023 | 41.72% | 花旗集團 | →$625 | 恢復 | 購買→購買 |
07/28/2023 | 17.91% | 富國銀行 | $505→$520 | 維護 | 體重不足 |
07/28/2023 | 42.86% | 雷蒙德·詹姆斯 | $595→$630 | 維護 | 跑贏大盤 |
07/27/2023 | 45.12% | 摩根士丹利 | $620→$640 | 維護 | 超重 |
07/27/2023 | 58.28% | 加拿大皇家銀行資本 | $662→$698 | 維護 | 跑贏大盤 |
07/27/2023 | 51.93% | 摩根大通 | $660→$670 | 維護 | 超重 |
07/27/2023 | 41.72% | 貝爾德 | $664→$625 | 維護 | 跑贏大盤 |
07/27/2023 | 41.72% | 巴克萊 | $590→$625 | 維護 | 超重 |
07/13/2023 | 40.59% | 瑞士信貸 | →$620 | 升級 | 中性→表現優異 |
2023年05月25日 | 49.66% | 摩根大通 | $675→$660 | 維護 | 超重 |
2023年05月25日 | 45.12% | KeyBanc | $710→$640 | 維護 | 超重 |
04/27/2023 | 47.39% | 花旗集團 | $700→$650 | 維護 | 買 |
04/27/2023 | 50.11% | 加拿大皇家銀行資本 | $664→$662 | 維護 | 跑贏大盤 |
04/27/2023 | 40.59% | 摩根士丹利 | $670→$620 | 維護 | 超重 |
04/27/2023 | 57.14% | TD Cowen | $711→$693 | 維護 | 跑贏大盤 |
04/27/2023 | 51.93% | 貝爾德 | $693→$670 | 維護 | 跑贏大盤 |
04/27/2023 | 38.32% | 巴克萊 | $625→$610 | 維護 | 超重 |
04/04/2023 | 38.32% | Evercore ISI集團 | $615→$610 | 維護 | 跑贏大盤 |
04/04/2023 | 41.72% | 巴克萊 | $660→$625 | 維護 | 超重 |
02/02/2023 | 53.06% | 摩根大通 | $650→$675 | 維護 | 超重 |
02/02/2023 | 61.22% | 考恩公司 | $690→$711 | 維護 | 跑贏大盤 |
02/02/2023 | 58.73% | 花旗集團 | $650→$700 | 維護 | 買 |
02/02/2023 | 51.93% | 摩根士丹利 | $613→$670 | 維護 | 超重 |
02/02/2023 | 49.66% | 巴克萊 | $630→$660 | 維護 | 超重 |
02/02/2023 | 42.86% | SVB Leerink | $620→$630 | 維護 | 跑贏大盤 |
01/24/2023 | 42.86% | 巴克萊 | $570→$630 | 維護 | 超重 |
01/06/2023 | 40.59% | SVB Leerink | $555→$620 | 維護 | 跑贏大盤 |
01/03/2023 | 14.51% | 富國銀行 | $525→$505 | 維護 | 體重不足 |
2022年12月14日 | 40.59% | 德意志銀行 | →$620 | 開始承保 | →購買 |
12/07/2022 | 49.89% | 加拿大皇家銀行資本 | →$661 | 開始承保 | →跑贏大盤 |
2022年11月29日 | 29.25% | 巴克萊 | $575→$570 | 維護 | 超重 |
11/01/2022 | 50.79% | 貝爾德 | $695→$665 | 維護 | 跑贏大盤 |
10/27/2022 | 47.39% | 摩根大通 | $715→$650 | 維護 | 超重 |
10/27/2022 | 47.39% | 花旗集團 | $715→$650 | 維護 | 買 |
10/27/2022 | 30.39% | 巴克萊 | $595→$575 | 維護 | 超重 |
10/27/2022 | 39% | 摩根士丹利 | $678→$613 | 維護 | 超重 |
10/27/2022 | 25.85% | SVB Leerink | $590→$555 | 維護 | 跑贏大盤 |
09/12/2022 | 34.92% | 巴克萊 | $685→$595 | 維護 | 超重 |
2022年08月25日 | 53.06% | 瑞士信貸 | →$675 | 開始承保 | →中性 |
08/01/2022 | 55.33% | 巴克萊 | $630→$685 | 維護 | 超重 |
07/29/2022 | 62.13% | 摩根大通 | $700→$715 | 維護 | 超重 |
07/29/2022 | 53.74% | 摩根士丹利 | $670→$678 | 維護 | 超重 |
07/29/2022 | 47.39% | SVB Leerink | $630→$650 | 維護 | 跑贏大盤 |
07/13/2022 | 42.86% | 巴克萊 | $675→$630 | 維護 | 超重 |
04/29/2022 | 51.93% | 摩根士丹利 | $700→$670 | 維護 | 超重 |
04/25/2022 | 19.05% | 富國銀行 | $605→$525 | 評級下調 | 等重→減碼 |
02/03/2022 | 37.19% | 富國銀行 | $700→$605 | 維護 | 等重 |
2021年12月14日 | 58.73% | 富國銀行 | $625→$700 | 維護 | 等重 |
10/28/2021 | 62.13% | 花旗集團 | $700→$715 | 維護 | 買 |
10/28/2021 | 55.33% | SVB Leerink | $675→$685 | 維護 | 跑贏大盤 |
10/20/2021 | 58.73% | 花旗集團 | $620→$700 | 升級 | 中性→購買 |
09/23/2021 | 48.53% | 考恩公司 | $560→$655 | 維護 | 跑贏大盤 |
09/22/2021 | 58.73% | BTIG | $610→$700 | 維護 | 買 |
09/20/2021 | 58.73% | 摩根大通 | $600→$700 | 維護 | 超重 |
09/20/2021 | 61% | KeyBanc | $555→$710 | 維護 | 超重 |
08/04/2021 | 36.05% | Argus研究 | $530→$600 | 維護 | 買 |
07/29/2021 | 36.05% | 摩根大通 | $560→$600 | 維護 | 超重 |
07/16/2021 | 31.52% | 基準 | →$580 | 開始承保 | →購買 |
07/12/2021 | 25.85% | KeyBanc | $520→$555 | 維護 | 超重 |
2021/06/23 | 24.72% | 貝爾德 | $545→$550 | 維護 | 跑贏大盤 |
2021/06/15 | 20.18% | 高盛 | $590→$530 | 維護 | 買 |
04/16/2021 | 22.45% | Evercore ISI集團 | $525→$540 | 維護 | 跑贏大盤 |
03/29/2021 | 26.98% | 瑞銀集團 | $588→$560 | 維護 | 買 |
03/18/2021 | 17.91% | KeyBanc | →$520 | 升級 | 行業權重→超配 |
03/03/2021 | 19.05% | 巴克萊 | →$525 | 開始承保 | →超重 |
02/03/2021 | 33.79% | BTIG | $540→$590 | 維護 | 買 |
02/02/2021 | 20.18% | 花旗集團 | $500→$530 | 維護 | 買 |
02/02/2021 | 33.33% | 瑞銀集團 | $566→$588 | 維護 | 買 |
02/02/2021 | 32.65% | 考恩公司 | $525→$585 | 維護 | 跑贏大盤 |
02/02/2021 | 36.05% | Stifel | $530→$600 | 維護 | 買 |
02/02/2021 | 30.39% | 摩根士丹利 | $535→$575 | 維護 | 超重 |
02/02/2021 | 26.98% | SVB Leerink | $525→$560 | 維護 | 跑贏大盤 |
2021/12/01 | 31.52% | 瑞士信貸 | $556→$580 | 維護 | 跑贏大盤 |
01/08/2021 | 26.08% | 瑞士信貸 | $490→$556 | 升級 | 中性→表現優異 |
12/16/2020 | - | 花旗集團 | 評級下調 | 購買→中性 | |
12/02/2020 | 11.11% | 瑞士信貸 | $488→$490 | 維護 | 中性 |
11/10/2020 | - | KeyBanc | 開始承保 | →行業權重 | |
10/22/2020 | 10.66% | 瑞士信貸 | $432→$488 | 維護 | 中性 |
10/22/2020 | 21.32% | 摩根士丹利 | $485→$535 | 維護 | 超重 |
10/22/2020 | 19.05% | SVB Leerink | $470→$525 | 維護 | 跑贏大盤 |
09/30/2020 | - | 大西洋證券公司 | 開始承保 | →超重 | |
09/17/2020 | 8.16% | 李約瑟 | $468→$477 | 維護 | 買 |
09/14/2020 | 9.98% | 摩根士丹利 | →$485 | 開始承保 | →超重 |
09/11/2020 | 8.84% | B of A證券 | $460→$480 | 維護 | 買 |
09/11/2020 | -2.04% | 瑞士信貸 | $425→$432 | 維護 | 中性 |
09/11/2020 | 6.58% | SVB Leerink | $455→$470 | 維護 | 跑贏大盤 |
2020年08月21日 | -3.63% | 瑞士信貸 | $405→$425 | 維護 | 中性 |
08/20/2020 | 4.31% | 摩根大通 | →$460 | 恢復 | →超重 |
07/23/2020 | 6.12% | 李約瑟 | $415→$468 | 維護 | 買 |
07/23/2020 | 3.17% | SVB Leerink | $365→$455 | 維護 | 跑贏大盤 |
07/15/2020 | - | 克利夫蘭研究公司 | 升級 | 中性→購買 | |
07/07/2020 | -5.9% | 李約瑟 | $383→$415 | 維護 | 買 |
04/23/2020 | -11.56% | 花旗集團 | $365→$390 | 維護 | 買 |
04/23/2020 | -13.15% | 李約瑟 | $341→$383 | 維護 | 買 |
04/21/2020 | -22.9% | 富國銀行 | $300→$340 | 維護 | 等重 |
04/02/2020 | -28.57% | Stifel | $345→$315 | 維護 | 買 |
03/30/2020 | -31.97% | 富國銀行 | $345→$300 | 維護 | 等重 |
03/20/2020 | -17.23% | 花旗集團 | $390→$365 | 維護 | 買 |
03/04/2020 | -22.68% | 貝爾德 | $340→$341 | 維護 | 跑贏大盤 |
2020/01/31 | -15.65% | BTIG | $342→$372 | 維護 | 買 |
2020/01/31 | -22.9% | 貝爾德 | $319→$340 | 維護 | 跑贏大盤 |
2020/01/31 | -21.77% | 富國銀行 | $350→$345 | 維護 | 等重 |
2020/01/31 | -11.56% | 花旗集團 | $380→$390 | 維護 | 買 |
2020/01/22 | -22.68% | 瑞士信貸 | →$341 | 開始承保 | →中性 |
1/08/2020 | -20.63% | 富國銀行 | →$350 | 開始承保 | →等重 |
1/07/2020 | -13.83% | 花旗集團 | →$380 | 開始承保 | →購買 |
2019年11月15日 | -21.77% | Stifel | →$345 | 開始承保 | →購買 |
2019年10月24日 | -27.66% | 貝爾德 | $305→$319 | 維護 | 跑贏大盤 |
2019年07月25日 | -27.21% | 李約瑟 | $315→$321 | 維護 | 買 |
2019年07月16日 | -28.57% | 李約瑟 | →$315 | 評級下調 | 強買通→買 |
2019年05月23日 | -27.44% | 瑞銀集團 | $305→$320 | 維護 | 買 |
2019年05月01日 | -29.71% | Argus研究 | $285→$310 | 維護 | 買 |
2019年03月26日 | -34.69% | 貝爾德 | $270→$288 | 維護 | 跑贏大盤 |
2019/03/22 | -31.97% | 德意志銀行 | $275→$300 | 維護 | 買 |
2019/03/18 | -31.97% | 巴克萊 | $295→$300 | 維護 | 超重 |
2019年03月01日 | -36.51% | 巴克萊 | $275→$280 | 維護 | 超重 |
2019年03月01日 | -38.55% | 李約瑟 | →$271 | 開始承保 | →強勢購買 |
What is the target price for Thermo Fisher Scientific (TMO)?
Thermo Fisher Science(TMO)的目標價是多少?
The latest price target for Thermo Fisher Scientific (NYSE: TMO) was reported by Citigroup on October 26, 2023. The analyst firm set a price target for $530.00 expecting TMO to rise to within 12 months (a possible 20.18% upside). 46 analyst firms have reported ratings in the last year.
花旗集團於2023年10月26日報道了Thermo Fisher Science(紐約證券交易所代碼:TMO)的最新目標價。這家分析公司將目標價定為530.00美元,預計TMO將在12個月內上漲至20.18%。去年,46家分析公司公佈了評級。
What is the most recent analyst rating for Thermo Fisher Scientific (TMO)?
Thermo Fisher Science(TMO)的最新分析師評級是多少?
The latest analyst rating for Thermo Fisher Scientific (NYSE: TMO) was provided by Citigroup, and Thermo Fisher Scientific maintained their buy rating.
對Thermo Fisher Science(紐約證券交易所代碼:TMO)的最新分析師評級由花旗集團提供,Thermo Fisher Science維持其買入評級。
When is the next analyst rating going to be posted or updated for Thermo Fisher Scientific (TMO)?
Thermo Fisher Science(TMO)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Thermo Fisher Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Thermo Fisher Scientific was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
分析師在進行廣泛的研究後得出股票評級,研究內容包括查閱公開財務報表、與賽默飛世爾科技公司的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月做一次,所以你每年應該對每家公司進行4次評級。Thermo Fisher Scientific的最後一次評級於2023年10月26日提交,因此您應該期待下一次評級將在2024年10月26日左右提供。
Is the Analyst Rating Thermo Fisher Scientific (TMO) correct?
分析師對Thermo Fisher Science(TMO)的評級正確嗎?
While ratings are subjective and will change, the latest Thermo Fisher Scientific (TMO) rating was a maintained with a price target of $625.00 to $530.00. The current price Thermo Fisher Scientific (TMO) is trading at is $441.00, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Thermo Fisher Science(TMO)評級維持不變,目標價在625.00美元至530.00美元之間。目前Thermo Fisher Science的交易價格為441.00美元,超出了分析師的預測範圍。